Ischemic Heart Disease, Atherosclerosis, and Longevity
1966; Lippincott Williams & Wilkins; Volume: 34; Issue: 4 Linguagem: Inglês
10.1161/01.cir.34.4.679
ISSN1524-4539
AutoresJohn W. Gofman, Wei Young, Robert Tandy,
Tópico(s)Cardiac Health and Mental Health
ResumoHomeCirculationVol. 34, No. 4Ischemic Heart Disease, Atherosclerosis, and Longevity Free AccessResearch ArticlePDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessResearch ArticlePDF/EPUBIschemic Heart Disease, Atherosclerosis, and Longevity JOHN W. GOFMAN, WEI YOUNG and ROBERT TANDY JOHN W. GOFMANJOHN W. GOFMAN From the University of California, Bio-Medical Research Division, Lawrence Radiation Laboratory, Livermore, California. , WEI YOUNGWEI YOUNG From the University of California, Bio-Medical Research Division, Lawrence Radiation Laboratory, Livermore, California. and ROBERT TANDYROBERT TANDY From the University of California, Bio-Medical Research Division, Lawrence Radiation Laboratory, Livermore, California. Originally published1 Oct 1966https://doi.org/10.1161/01.CIR.34.4.679Circulation. 1966;34:679–697 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Johnson B, Stevenson A, Barrett L, Fear M, Wood F and Linden M (2022) Platelets after burn injury – hemostasis and beyond, Platelets, 10.1080/09537104.2021.1981849, 33:5, (655-665), Online publication date: 4-Jul-2022. Kalayci A, Gibson C, Ridker P, Wright S, Kingwell B, Korjian S, Chi G, Lee J, Tricoci P, Kazmi S, Fitzgerald C, Shaunik A, Berman G, Duffy D and Libby P (2022) ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future, Current Atherosclerosis Reports, 10.1007/s11883-022-01025-7, 24:7, (585-597), Online publication date: 1-Jul-2022. Abe R, Abe J, Nguyen M, Olmsted-Davis E, Mamun A, Banerjee P, Cooke J, Fang L, Pownall H and Le N (2022) Free Cholesterol Bioavailability and Atherosclerosis, Current Atherosclerosis Reports, 10.1007/s11883-022-01011-z, 24:5, (323-336), Online publication date: 1-May-2022. Superko H and Garrett B (2022) Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence Still a Risk Even with 'Normal' LDL-C Levels, Biomedicines, 10.3390/biomedicines10040829, 10:4, (829) Ong K, Cochran B, Manandhar B, Thomas S and Rye K (2022) HDL maturation and remodelling, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 10.1016/j.bbalip.2022.159119, 1867:4, (159119), Online publication date: 1-Apr-2022. Liu J, Gillard B, Yelamanchili D, Gotto A, Rosales C and Pownall H (2021) High Free Cholesterol Bioavailability Drives the Tissue Pathologies in Scarb1−/− Mice, Arteriosclerosis, Thrombosis, and Vascular Biology, 41:10, (e453-e467), Online publication date: 1-Oct-2021. Pownall H, Rosales C, Gillard B and Gotto A (2021) High-density lipoproteins, reverse cholesterol transport and atherogenesis, Nature Reviews Cardiology, 10.1038/s41569-021-00538-z, 18:10, (712-723), Online publication date: 1-Oct-2021. Penson P and Banach M (2021) Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice, Nutrients, 10.3390/nu13092957, 13:9, (2957) Banach M and Penson P (2021) Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies, Current Atherosclerosis Reports, 10.1007/s11883-021-00932-5, 23:7, Online publication date: 1-Jul-2021. Rao S, Kurakula M, Mamidipalli N, Tiyyagura P, Patel B and Manne R (2021) Pharmacological Exploration of Phenolic Compound: Raspberry Ketone—Update 2020, Plants, 10.3390/plants10071323, 10:7, (1323) Giammanco A, Noto D, Barbagallo C, Nardi E, Caldarella R, Ciaccio M, Averna M and Cefalù A (2021) Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases, Life, 10.3390/life11060581, 11:6, (581) Penson P and Banach M (2021) Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes, Atherosclerosis, 10.1016/j.atherosclerosis.2020.11.015, 316, (58-65), Online publication date: 1-Jan-2021. Baliga R, Yang E and Bossone E (2020) Linear reverse risk of HDL-C levels for predicting cardiovascular disease: it is not that straightforward!, European Journal of Preventive Cardiology, 10.1093/eurjpc/zwaa032 Murphy C, Deplazes E, Cranfield C and Garcia A (2020) The Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins, International Journal of Molecular Sciences, 10.3390/ijms21228745, 21:22, (8745) Penson P and Banach M (2020) The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia, Current Atherosclerosis Reports, 10.1007/s11883-020-00887-z, 22:11, Online publication date: 1-Nov-2020. Roberts R and Chang C A Journey through Genetic Architecture and Predisposition of Coronary Artery Disease, Current Genomics, 10.2174/1389202921999200630145241, 21:5, (382-398) Arjmandnia M, Vahedian M, Yyosefi M, Amouei M, Rezvan S, Assi M, Siamaki M, Barati A, Naderi A and Sharifi A (2020) Relationship between vitamin D consumption during pregnancy and neonatal congenital heart disease, Journal of Vessels and Circulation, 10.52547/jvesselcirc.1.3.13, 1:3, (13-17) Rosales C, Gillard B, Gotto A and Pownall H (2020) The Alcohol–High-Density Lipoprotein Athero-Protective Axis, Biomolecules, 10.3390/biom10070987, 10:7, (987) Spiller W, Jung K, Lee J and Jee S (2020) Precision Medicine and Cardiovascular Health: Insights from Mendelian Randomization Analyses, Korean Circulation Journal, 10.4070/kcj.2019.0293, 50:2, (91) Castaño D, Rattanasopa C, Monteiro-Cardoso V, Corlianò M, Liu Y, Zhong S, Rusu M, Liehn E and Singaraja R (2020) Lipid efflux mechanisms, relation to disease and potential therapeutic aspects, Advanced Drug Delivery Reviews, 10.1016/j.addr.2020.04.013, 159, (54-93), . Li X, Guan B, Wang Y, Tse G, Zou F, Khalid B, Xia Y, Wu S and Sun J (2019) Association between high-density lipoprotein cholesterol and all-cause mortality in the general population of northern China, Scientific Reports, 10.1038/s41598-019-50924-4, 9:1, Online publication date: 1-Dec-2019. Jones-O'Connor M and Natarajan P (2019) Optimal Non-invasive Strategies to Reduce Recurrent Atherosclerotic Cardiovascular Disease Risk, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-019-0741-4, 21:8, Online publication date: 1-Aug-2019. Xiang A and Kingwell B (2019) Rethinking good cholesterol: a clinicians' guide to understanding HDL, The Lancet Diabetes & Endocrinology, 10.1016/S2213-8587(19)30003-8, 7:7, (575-582), Online publication date: 1-Jul-2019. Nemethova A, Nemeth M, Michalconok G and Bohm A (2019) Identification of KDD Problems from Medical Data Artificial Intelligence Methods in Intelligent Algorithms, 10.1007/978-3-030-19810-7_19, (191-199), . Wang J, Shi L, Zou Y, Tang J, Cai J, Wei Y, Qin J and Zhang Z (2018) Positive association of familial longevity with the moderate-high HDL-C concentration in Bama Aging Study, Aging, 10.18632/aging.101663, 10:11, (3528-3540), Online publication date: 28-Nov-2018. Roberts R (2018) Mendelian Randomization Studies Promise to Shorten the Journey to FDA Approval, JACC: Basic to Translational Science, 10.1016/j.jacbts.2018.08.001, 3:5, (690-703), Online publication date: 1-Oct-2018. Niisuke K, Horvath K and Asztalos B (2018) Where next with HDL assays?, Current Opinion in Lipidology, 10.1097/MOL.0000000000000529, 29:4, (293-298), Online publication date: 1-Aug-2018. Rhainds D, Brodeur M and Tardif J (2018) Lipids, Apolipoproteins, and Inflammatory Biomarkers of Cardiovascular Risk: What Have We Learned?, Clinical Pharmacology & Therapeutics, 10.1002/cpt.1114, 104:2, (244-256), Online publication date: 1-Aug-2018. Matera R, Horvath K, Nair H, Schaefer E and Asztalos B (2018) HDL Particle Measurement: Comparison of 5 Methods, Clinical Chemistry, 10.1373/clinchem.2017.277632, 64:3, (492-500), Online publication date: 1-Mar-2018. Wang H, Garruti G, Liu M, Portincasa P and Wang D (2017) Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport, Annals of Hepatology, 10.5604/01.3001.0010.5495, 16, (S27-S42), Online publication date: 1-Nov-2017. Iqbal F, Baker W, Khan M, Thukuntla S, McKinney K, Abate N and Tuvdendorj D (2017) Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism, British Journal of Pharmacology, 10.1111/bph.13743, 174:22, (3986-4006), Online publication date: 1-Nov-2017. Anassori E, Dalir-Naghadeh B, Valizadeh-Keshmeshtappeh M and Jafari S (2017) A comparative study on the efficacy of Garlicon and monensin supplementation on blood metabolites and performance of fattening lambs, Livestock Science, 10.1016/j.livsci.2017.03.014, 199, (74-78), Online publication date: 1-May-2017. Baldán Á and de Aguiar Vallim T (2016) miRNAs and High-Density Lipoprotein metabolism, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 10.1016/j.bbalip.2016.01.021, 1861:12, (2053-2061), Online publication date: 1-Dec-2016. Siri-Tarino P and Krauss R (2016) The early years of lipoprotein research: from discovery to clinical application, Journal of Lipid Research, 10.1194/jlr.R069575, 57:10, (1771-1777), Online publication date: 1-Oct-2016. Zolla L, D'Alessandro A and Lana A (2016) Chromatography of Membrane Proteins and Lipoproteins Encyclopedia of Analytical Chemistry, 10.1002/9780470027318.a1607.pub3, (1-46) Liu J, Hernandez-Ono A, Graham M, Galton V and Ginsberg H (2016) Type 1 Deiodinase Regulates ApoA-I Gene Expression and ApoA-I Synthesis Independent of Thyroid Hormone Signaling, Arteriosclerosis, Thrombosis, and Vascular Biology, 36:7, (1356-1366), Online publication date: 1-Jul-2016.Canfrán-Duque A, Lin C, Goedeke L, Suárez Y and Fernández-Hernando C (2016) Micro-RNAs and High-Density Lipoprotein Metabolism, Arteriosclerosis, Thrombosis, and Vascular Biology, 36:6, (1076-1084), Online publication date: 1-Jun-2016. Tikka A and Jauhiainen M (2016) The role of ANGPTL3 in controlling lipoprotein metabolism, Endocrine, 10.1007/s12020-015-0838-9, 52:2, (187-193), Online publication date: 1-May-2016. Rosales C, Davidson W, Gillard B, Gotto A and Pownall H (2016) Speciated High-Density Lipoprotein Biogenesis and Functionality, Current Atherosclerosis Reports, 10.1007/s11883-016-0572-7, 18:5, Online publication date: 1-May-2016. Negi P, Lövgren J, Malmi P, Sirkka N, Metso J, Huovinen T, Brockmann E, Pettersson K, Jauhiainen M and Lamminmäki U (2016) Identification and analysis of anti-HDL scFv-antibodies obtained from phage display based synthetic antibody library, Clinical Biochemistry, 10.1016/j.clinbiochem.2015.11.020, 49:6, (472-479), Online publication date: 1-Apr-2016. Joshi P, Toth P, Lirette S, Griswold M, Massaro J, Martin S, Blaha M, Kulkarni K, Khokhar A, Correa A, D'Agustino R and Jones S (2014) Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort Studies, European Journal of Preventive Cardiology, 10.1177/2047487314543890, 23:1, (41-49), Online publication date: 1-Jan-2016. Pownall H and Gotto A (2016) New Insights into the High-Density Lipoprotein Dilemma, Trends in Endocrinology & Metabolism, 10.1016/j.tem.2015.11.004, 27:1, (44-53), Online publication date: 1-Jan-2016. Martin S, Joshi P and Michos E (2016) Lipids in Coronary Heart Disease Translational Research in Coronary Artery Disease, 10.1016/B978-0-12-802385-3.00007-3, (67-80), . Hopkins P, Pottala J and Nanjee M (2015) A comparative study of four independent methods to measure LDL particle concentration, Atherosclerosis, 10.1016/j.atherosclerosis.2015.08.042, 243:1, (99-106), Online publication date: 1-Nov-2015. Rosales C, Gillard B, Gotto, Jr. A and Pownall H (2015) High-Density Lipoprotein Processing and Premature Cardiovascular Disease, Methodist DeBakey Cardiovascular Journal, 10.14797/mdcj-11-3-181, 11:3, (181) Williams K and Fisher E (2015) Apolipoprotein-B Atherosclerosis, 10.1002/9781118828533.ch24, (291-312) Anassori E, Dalir-Naghadeh B, Pirmohammadi R and Hadian M (2014) Changes in blood profile in sheep receiving raw garlic, garlic oil or monensin, Journal of Animal Physiology and Animal Nutrition, 10.1111/jpn.12189, 99:1, (114-122), Online publication date: 1-Feb-2015. Martin S, Khokhar A, May H, Kulkarni K, Blaha M, Joshi P, Toth P, Muhlestein J, Anderson J, Knight S, Li Y, Spertus J and Jones S (2014) HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborative, European Heart Journal, 10.1093/eurheartj/ehu264, 36:1, (22-30), Online publication date: 1-Jan-2015. Gotto A and Pownall H (2015) Prevention and Treatment of Atherosclerotic Vascular Disease: Hypolipidemic Agents Pathophysiology and Pharmacotherapy of Cardiovascular Disease, 10.1007/978-3-319-15961-4_28, (589-611), . Savolainen M (2015) Epidemiology: Disease Associations and Modulators of HDL-Related Biomarkers High Density Lipoproteins, 10.1007/978-3-319-09665-0_7, (259-283), . Martin S, Joshi P and Blaha M (2014) High-density lipoprotein and endothelial function in patients with myocardial infarction: Pieces in a puzzle, Atherosclerosis, 10.1016/j.atherosclerosis.2014.10.026, 237:2, (838-839), Online publication date: 1-Dec-2014. Lin G, Li Y and Han C (2014) Elevated concentrations of high-density lipoprotein cholesterol and cardiovascular risk paradox in patients with coronary heart disease and the equivalents, International Journal of Cardiology, 10.1016/j.ijcard.2014.07.153, 176:3, (1316-1317), Online publication date: 1-Oct-2014. Martin S, Jones S and Toth P (2014) High-density lipoprotein subfractions: current views and clinical practice applications, Trends in Endocrinology & Metabolism, 10.1016/j.tem.2014.05.005, 25:7, (329-336), Online publication date: 1-Jul-2014. Roberts R (2014) Genetics of Coronary Artery Disease, Circulation Research, 114:12, (1890-1903), Online publication date: 6-Jun-2014.Krauss R (2014) All Low-Density Lipoprotein Particles Are Not Created Equal, Arteriosclerosis, Thrombosis, and Vascular Biology, 34:5, (959-961), Online publication date: 1-May-2014. Kleber M, Grammer T, Kassner U, Silbernagel G and März W (2014) Dusty Punch Cards and an Eternal Enigma: High-Density Lipoproteins and Atherosclerosis, Drugs, 10.1007/s40265-014-0189-5, 74:5, (513-520), Online publication date: 1-Apr-2014. Akinkuolie A, Paynter N, Padmanabhan L and Mora S (2013) High-Density Lipoprotein Particle Subclass Heterogeneity and Incident Coronary Heart Disease, Circulation: Cardiovascular Quality and Outcomes, 7:1, (55-63), Online publication date: 1-Jan-2014. Cobble M, Mize P and Brinton E (2014) Lipoprotein Subclasses and Cardiovascular Disease Risk in Insulin-Resistant Diabetes Lipoproteins in Diabetes Mellitus, 10.1007/978-1-4614-7554-5_2, (11-40), . Hsieh J, Chang C, Huang M, Chang C, Chen C, Shen M, Liao H, Wang G, Chen C, Chen C and Yang C (2013) Biochemical and Functional Characterization of Charge-Defined Subfractions of High-Density Lipoprotein From Normal Adults, Analytical Chemistry, 10.1021/ac402516u, 85:23, (11440-11448), Online publication date: 3-Dec-2013. Pownall H, Gillard B and Gotto A (2017) Setting the course for apoAII: a port in sight?, Clinical Lipidology, 10.2217/clp.13.59, 8:5, (551-560), Online publication date: 1-Oct-2013. Ashmaig M, Gupta S, McConnell J and Warnick G (2013) Validation of a novel homogeneous assay for of HDL3-C measurement, Clinica Chimica Acta, 10.1016/j.cca.2013.07.007, 425, (37-41), Online publication date: 1-Oct-2013. Toth P, Barter P, Rosenson R, Boden W, Chapman M, Cuchel M, D'Agostino R, Davidson M, Davidson W, Heinecke J, Karas R, Kontush A, Krauss R, Miller M and Rader D (2013) High-density lipoproteins: A consensus statement from the National Lipid Association, Journal of Clinical Lipidology, 10.1016/j.jacl.2013.08.001, 7:5, (484-525), Online publication date: 1-Sep-2013. Medford R, Dagi T, Rosenson R and Offermann M (2013) Biomarkers and Sustainable Innovation in Cardiovascular Drug Development: Lessons from Near and Far Afield, Current Atherosclerosis Reports, 10.1007/s11883-013-0321-0, 15:5, Online publication date: 1-May-2013. Superko H, Pendyala L, Williams P, Momary K, King S and Garrett B (2012) High-density lipoprotein subclasses and their relationship to cardiovascular disease, Journal of Clinical Lipidology, 10.1016/j.jacl.2012.03.001, 6:6, (496-523), Online publication date: 1-Nov-2012. Williams K (2012) What does HDL do? A new mechanism to slow atherogenesis – But a new problem in type 2 diabetes mellitus, Atherosclerosis, 10.1016/j.atherosclerosis.2012.06.023, 225:1, (36-38), Online publication date: 1-Nov-2012. Liu M and Williams K (2012) Microvesicles, Current Opinion in Endocrinology, Diabetes & Obesity, 10.1097/MED.0b013e32835057e9, 19:2, (121-127), Online publication date: 1-Apr-2012. Williams P (2012) Low High‐Density Lipoprotein 3 Reduces the Odds of Men Surviving to Age 85 During 53‐Year Follow‐Up, Journal of the American Geriatrics Society, 10.1111/j.1532-5415.2011.03851.x, 60:3, (430-436), Online publication date: 1-Mar-2012. Williams P (2012) Fifty-three year follow-up of coronary heart disease versus HDL2 and other lipoproteins in Gofman's Livermore Cohort, Journal of Lipid Research, 10.1194/jlr.M019356, 53:2, (266-272), Online publication date: 1-Feb-2012. Gerber P, Spinas G and Berneis K (2012) Small dense low-density lipoprotein particles: priority as a treatment target in Type 2 diabetes?, Diabetes Management, 10.2217/dmt.11.73, 2:1, (65-74), Online publication date: 1-Jan-2012. Ferreira González I (2012) Situación actual del tratamiento de las dislipemias en España, Revista Española de Cardiología Suplementos, 10.1016/S1131-3587(12)70038-9, 12, (2-7), Online publication date: 1-Jan-2012. (2011) Frontmatter High-Density Lipoproteins, 10.1002/9781118158678.fmatter, (i-xxxvi) (2011) Epidemiology High-Density Lipoproteins, 10.1002/9781118158678.ch5, (113-160) (2011) Heterogeneity High-Density Lipoproteins, 10.1002/9781118158678.ch2, (39-58) Ghorbel H, Feki I, Friha I, Khabir A, Boudawara T, Boudawara M and Sayadi S (2011) Biochemical and histological liver changes occurred after iron supplementation and possible remediation by garlic consumption, Endocrine, 10.1007/s12020-011-9483-0, 40:3, (462-471), Online publication date: 1-Dec-2011. Rosenson R, Brewer H, Chapman M, Fazio S, Hussain M, Kontush A, Krauss R, Otvos J, Remaley A and Schaefer E (2011) HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events, Clinical Chemistry, 10.1373/clinchem.2010.155333, 57:3, (392-410), Online publication date: 1-Mar-2011. Williams P and Feldman D (2011) Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort, Atherosclerosis, 10.1016/j.atherosclerosis.2010.10.024, 214:1, (196-202), Online publication date: 1-Jan-2011. Wilson P (2011) Newer Coronary Risk Factors Atlas of Atherosclerosis and Metabolic Syndrome, 10.1007/978-1-4419-5839-6_6, (113-139), . Musunuru K (2010) Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention, Lipids, 10.1007/s11745-010-3408-1, 45:10, (907-914), Online publication date: 1-Oct-2010. Krauss R (2010) Lipoprotein subfractions and cardiovascular disease risk, Current Opinion in Lipidology, 10.1097/MOL.0b013e32833b7756, 21:4, (305-311), Online publication date: 1-Aug-2010. Hann A and Peckham S (2010) Cholesterol screening and the Gold Effect, Health, Risk & Society, 10.1080/13698570903499608, 12:1, (33-50), Online publication date: 1-Feb-2010. Kolovou G, Stamatelatou M, Anagnostopoulou K, Kostakou P, Kolovou V, Mihas C, Vasiliadis I, Diakoumakou O, Mikhailidis D and Cokkinos D Cholesteryl Ester Transfer Protein Gene Polymorphisms and Longevity Syndrome, The Open Cardiovascular Medicine Journal, 10.2174/1874192401004010014, 4:1, (14-19) Inazu A (2010) Plasma Cholesteryl Ester Transfer Protein (CETP) in Relation to Human Pathophysiology The HDL Handbook, 10.1016/B978-0-12-382171-3.10003-8, (35-59), . Schaefer E and Santos R (2010) High Density Lipoproteins, Dyslipidemia, and Heart Disease: Past, Present, and Future High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease, 10.1007/978-1-4419-1059-2_23, (181-199), . Superko H (2009) Cardiovascular Event Risk, Journal of the American College of Cardiology, 10.1016/j.jacc.2009.07.006, 54:14, (1246-1248), Online publication date: 1-Sep-2009. Soran H, Younis N, Charlton-Menys V and Durrington P (2009) Variation in paraoxonase-1 activity and atherosclerosis, Current Opinion in Lipidology, 10.1097/MOL.0b013e32832ec141, 20:4, (265-274), Online publication date: 1-Aug-2009. Chirovsky D, Fedirko V, Cui Y, Sazonov V and Barter P (2009) Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review, European Journal of Cardiovascular Prevention & Rehabilitation, 10.1097/HJR.0b013e32832c8891, 16:4, (404-423), Online publication date: 1-Aug-2009. Sacks F, Rudel L, Conner A, Akeefe H, Kostner G, Baki T, Rothblat G, de la Llera-Moya M, Asztalos B, Perlman T, Zheng C, Alaupovic P, Maltais J and Brewer H (2009) Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo, Journal of Lipid Research, 10.1194/jlr.M800622-JLR200, 50:5, (894-907), Online publication date: 1-May-2009. Superko H and Gadesam R (2008) Is it LDL particle size or number that correlates with risk for cardiovascular disease?, Current Atherosclerosis Reports, 10.1007/s11883-008-0059-2, 10:5, (377-385), Online publication date: 1-Oct-2008. Remaley A and Warnick G (2008) High-density lipoprotein: what is the best way to measure its antiatherogenic potential?, Expert Opinion on Medical Diagnostics, 10.1517/17530059.2.7.773, 2:7, (773-788), Online publication date: 1-Jul-2008. O'Donnell C and Elosua R (2008) Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study, Revista Española de Cardiología, 10.1157/13116658, 61:3, (299-310), Online publication date: 1-Mar-2008. Rasnake C, Trumbo P and Heinonen T (2008) Surrogate endpoints and emerging surrogate endpoints for risk reduction of cardiovascular disease, Nutrition Reviews, 10.1111/j.1753-4887.2007.00010.x, 66:2, (76-81) O'Donnell C and Elosua R (2008) Cardiovascular Risk Factors. Insights From Framingham Heart Study, Revista Española de Cardiología (English Edition), 10.1016/S1885-5857(08)60118-8, 61:3, (299-310), Online publication date: 1-Jan-2008. Michael Gaziano J and Buring J (2007) Alcohol Intake, Lipids and Risks of Myocardial Infarction Novartis Foundation Symposium 216 - Alcohol and Cardiovascular Diseases, 10.1002/9780470515549.ch7, (86-110) Milionis H, Kalantzi K, Papathanasiou A, Kosovitsas A, Doumas M and Goudevenos J (2007) Metabolic syndrome and risk of acute coronary syndromes in patients younger than 45 years of age, Coronary Artery Disease, 10.1097/MCA.0b013e328035f8c4, 18:4, (247-252), Online publication date: 1-Jun-2007. Cromwell W (2007) High-density lipoprotein associations with coronary heart disease: Does measurement of cholesterol content give the best result?, Journal of Clinical Lipidology, 10.1016/j.jacl.2007.01.002, 1:1, (57-64), Online publication date: 1-Mar-2007. Cromwell W and Otvos J (2007) Utilization of Lipoprotein Subfractions Therapeutic Lipidology, 10.1007/978-1-59745-533-6_15, (321-347), . Gomaraschi M, Calabresi L and Franceschini G (2006) High-density lipoproteins: a therapeutic target for atherosclerotic cardiovascular disease, Expert Opinion on Therapeutic Targets, 10.1517/14728222.10.4.561, 10:4, (561-572), Online publication date: 1-Aug-2006. McCaskie P, Cadby G, Hung J, McQuillan B, Chapman C, Carter K, Thompson P, Palmer L and Beilby J (2006) The C-480T hepatic lipase polymorphism is associated with HDL-C but not with risk of coronary heart disease, Clinical Genetics, 10.1111/j.1399-0004.2006.00659.x, 70:2, (114-121) Ruaño G, Seip R, Windemuth A, Zöllner S, Tsongalis G, Ordovas J, Otvos J, Bilbie C, Miles M, Zoeller R, Visich P, Gordon P, Angelopoulos T, Pescatello L, Moyna N and Thompson P (2006) Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training, Atherosclerosis, 10.1016/j.atherosclerosis.2005.05.029, 185:1, (65-69), Online publication date: 1-Mar-2006. Kolovou G, Anagnostopoulou K, Salpea K, Pilatis N, Grapsa G, Pantelakis A, Tsarpalis K, Kapnia E, Cokkinos D and Iraklianou S (2006) Postprandial Lipemia in Postmenopausal Women with High Fasting High-Density Lipoprotein Cholesterol, The American Journal of the Medical Sciences, 10.1097/00000441-200601000-00005, 331:1, (10-16), Online publication date: 1-Jan-2006. Foody J High-Density Lipoprotein Cholesterol, Triglycerides, and Coronary Artery Disease Preventive Cardiology, 10.1007/978-1-59745-096-6_5, (81-92) Cariappa M, Poornima K, Nandini M, Asha K and Kedilaya H (2005) Oxidant status and lipid profile in vegetarians and fish eaters, Indian Journal of Clinical Biochemistry, 10.1007/BF02893052, 20:1, (103-108), Online publication date: 1-Jan-2005. Tholstrup T, Hellgren L, Petersen M, Basu S, Straarup E, Schnohr P and Sandström B (2004) A Solid Dietary Fat Containing Fish Oil Redistributes Lipoprotein Subclasses without Increasing Oxidative Stress in Men, The Journal of Nutrition, 10.1093/jn/134.5.1051, 134:5, (1051-1057), Online publication date: 1-Oct-2004. Johnson J, Slentz C, Duscha B, Samsa G, McCartney J, Houmard J and Kraus W (2004) Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study, Atherosclerosis, 10.1016/j.atherosclerosis.2004.05.018, 176:2, (371-377), Online publication date: 1-Oct-2004. Ng D (2004) Treating low HDL—From bench to bedside, Clinical Biochemistry, 10.1016/j.clinbiochem.2004.04.005, 37:8, (649-659), Online publication date: 1-Aug-2004. Superko H (2003) Sophisticated Tests for Susceptibility to Atherosclerosis:An Added Value for Heart Hospitals, The American Heart Hospital Journal, 10.1111/j.1541-9215.2003.02362.x, 1:2, (135-140), Online publication date: 1-Apr-2003. Yu S, Yarnell J, Sweetnam P and Bolton C (2003) High density lipoprotein subfractions and the risk of coronary heart disease: 9-years follow-up in the Caerphilly Study, Atherosclerosis, 10.1016/S0021-9150(02)00361-1, 166:2, (331-338), Online publication date: 1-Feb-2003. Superko H and Chronos N (2003) Hypercholesterolemia and Dyslipidemia: Issues for the clinician, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-003-0013-0, 5:1, (35-50), Online publication date: 1-Feb-2003. Wilson P (2003) The Newer Coronary Risk Factors Atlas of Atherosclerosis, 10.1007/978-1-4615-6484-3_10, (193-211), . Hokanson J (2002) Hypertriglyceridemia and risk of coronary heart disease, Current Cardiology Reports, 10.1007/s11886-002-0112-7, 4:6, (488-493), Online publication date: 1-Nov-2002. Hokanson J, Cheng S, Snell-Bergeon J, Fijal B, Grow M, Hung C, Erlich H, Ehrlich J, Eckel R and Rewers M (2002) A Common Promoter Polymorphism in the Hepatic Lipase Gene ( LIPC -480C>T) Is Associated With an Increase in Coronary Calcification in Type 1 Diabetes , Diabetes, 10.2337/diabetes.51.4.1208, 51:4, (1208-1213), Online publication date: 1-Apr-2002. Kolovou G and Cokkinos D (2008) Low Serum Levels of High-density Lipoprotein Cholesterol and Hypolipidaemic Treatment, Current Medical Research and Opinion, 10.1185/030079902125000534, 18:5, (265-268), Online publication date: 1-Jan-2002. Franceschini G, Villa B, Gomaraschi M and Calabresi L (2002) The Low-HDL Syndrome: Epidemiology and Pathophysiology Peroxisome Proliferator Activated Receptors: From Basic Science to Clinical Applications, 10.1007/978-1-4615-1171-7_14, (103-108), . Srinivasan S, Segrest J, Elkasabany A and Berenson G (2001) Distribution and correlates of lipoproteins and their subclasses in black and white young adults. The Bogalusa Heart Study, Atherosclerosis, 10.1016/S0021-9150(01)00514-7, 159:2, (391-397), Online publication date: 1-Dec-2001. Franceschini G (2001) Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease, The American Journal of Cardiology, 10.1016/S0002-9149(01)02146-4, 88:12, (9-13), Online publication date: 1-Dec-2001. Stehbens W (2001) Coronary Heart Disease, Hypercholesterolemia, and Atherosclerosis II. Misrepresented Data, Experimental and Molecular Pathology, 10.1006/exmp.2000.2339, 70:2, (120-139), Online publication date: 1-Apr-2001. Elokdah H, Chai S, Ho D and Sulkowski T (2001) Design and synthesis of tricyclic derivatives as high density lipoprotein cholesterol enhancers, Bioorganic & Medicinal Chemistry Letters, 10.1016/S0960-894X(00)00668-5, 11:3, (339-342), Online publication date: 1-Feb-2001. Kurowska E, Spence J, Jordan J, Wetmore S, Freeman D, Piché L and Serratore P (2000) HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia, The American Journal of Clinical Nutrition, 10.1093/ajcn/72.5.1095, 72:5, (1095-1100), Online publication date: 1-Nov-2000. Furuya D, Yagihashi A, Nasu S, Endoh T, Nakamura T, Kaneko R, Kamagata C, Kobayashi D and Watanabe N (2000) LDL Particle Size by Gradient-Gel Electrophoresis Cannot Be Estimated by LDL-Cholesterol/Apolipoprotein B Ratios, Clinical Chemistry, 10.1093/clinchem/46.8.1202, 46:8, (1202-1203), Online publication date: 1-Aug-2000. Ferguson E (2000) Preventing, stopping, or reversing coronary artery disease— triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: The need for recognition and treatment, Disease-a-Month, 10.1016/S0011-5029(00)90011-7, 46:7, (421-503), Online publication date: 1-Jul-2000. Volek J, Gómez A and Kraemer W (2000) Fasting Lipoprotein and Postprandial Triacylglycerol Responses to a Low-Carbohydrate Diet Su
Referência(s)